![Sushmita Chanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sushmita Chanda
Corporate Officer/Principal bei
ALIGOS THERAPEUTICS, INC.
Profil
Sushmita M.
Chanda is Chief Development Officer & Executive VP at Aligos Therapeutics, Inc. since 2018.
Formerly, Dr. Chanda was Vice President-Preclinical Development at Alios BioPharma, Inc. from 2010 to 2018 and Senior Director & Head-Nonclinical Safety at F.
Hoffmann-La Roche Ltd. from 2000 to 2010.
Education includes a doctorate from the University of Louisiana at Monroe and undergraduate and graduate degrees from Birla Institute of Technology Mesra.
Aktive Positionen von Sushmita Chanda
| Unternehmen | Position | Beginn |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2018 |
Ehemalige bekannte Positionen von Sushmita Chanda
| Unternehmen | Position | Ende |
|---|---|---|
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Corporate Officer/Principal | 01.07.2018 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Sushmita Chanda
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
University of Louisiana at Monroe
 University of Louisiana at Monroe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Birla Institute of Technology Mesra
 Birla Institute of Technology Mesra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
